The Supreme Court ruled to keep mifepristone’s approval intact as litigation seeking to revoke the FDA-approved abortion pill continues to play out in lower courts.
Read the full post on Becker's Hospital Review - Healthcare News
The abortion pill case is poking the FDA. Is the agency bruised?
